These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6127517)

  • 1. Propranolol in decompensated alcoholic cirrhosis.
    Colman JC; Jennings GL; McLean AJ; Mignot PR; Dudley FJ
    Lancet; 1982 Nov; 2(8306):1040-1. PubMed ID: 6127517
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
    Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
    Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
    Gitlin N
    Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937
    [No Abstract]   [Full Text] [Related]  

  • 4. Propranolol in the treatment of portal hypertension: a caution.
    Conn HO
    Hepatology; 1982; 2(5):641-4. PubMed ID: 6981577
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothyroidism Enhanced Portal Hypertension in a Patient with Alcoholic Liver Cirrhosis, Resulting in the Development of Ascites.
    Kakisaka K; Endo K; Suzuki A; Hayashi S; Abe T; Yoshida Y; Oikawa T; Miyamoto Y; Sawara K; Ishida K; Kuroda H; Takikawa Y
    Intern Med; 2015; 54(18):2327-31. PubMed ID: 26370856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
    Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis.
    Kim MY; Baik SK; Yea CJ; Lee IY; Kim HJ; Park KW; Kim HK; Suk KT; Kim JW; Kim HS; Kwon SO; Cha SH; Kim YJ; Koh SB; Chang SJ
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1241-6. PubMed ID: 19455045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 9. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
    Schepke M; Wiest R; Flacke S; Heller J; Stoffel-Wagner B; Herold T; Ghauri M; Sauerbruch T
    Am J Gastroenterol; 2008 May; 103(5):1152-8. PubMed ID: 18422814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin decreases portal hypertension in the cirrhotic patient].
    Bories P; Pomier-Layrargues G; Chotard JP; Jacob C; Michel H
    Gastroenterol Clin Biol; 1980; 4(8-9):616-7. PubMed ID: 6107259
    [No Abstract]   [Full Text] [Related]  

  • 11. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of portal hypertension and esophageal varices in alcoholic cirrhosis.
    Trevillyan J; Carroll PJ
    Am Fam Physician; 1997 Apr; 55(5):1851-8, 1861-2. PubMed ID: 9105210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in the prevention of gastrointestinal bleeding.
    Lebrec L
    Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spastic paraparesis in alcoholic cirrhosis with portal systemic encephalopathy.
    Dhanwal DK; Das DK
    J Assoc Physicians India; 1998 Apr; 46(4):400. PubMed ID: 11273332
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol and portal hypertension in cirrhosis.
    Wilkinson RP
    Lancet; 1980 Aug; 2(8191):429. PubMed ID: 6105550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary hypertension associated with portal hypertension. Apropos of 2 cases].
    Mirode A; Tribouilloy C; Boulanger J; Adam MC; Trojette F; Lesbre JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1647-50. PubMed ID: 8746001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    Cho EJ; Kim MY; Lee JH; Lee IY; Lim YL; Choi DH; Kim YJ; Yoon JH; Baik SK
    PLoS One; 2015; 10(7):e0133935. PubMed ID: 26196942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine for portal hypertension: a sympathetic solution?
    Blendis LM
    Ann Intern Med; 1992 Mar; 116(6):515-7. PubMed ID: 1739244
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: assessment by duplex sonography.
    Zoller WG; Wagner DR; Zentner J
    Z Gastroenterol; 1993; 31(7-8):425-8. PubMed ID: 8379228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.